Table 2.
Ninety-day Complication Rates among Matched Groups with and without ADM Use in Implant-based Breast Reconstruction*
| ADM Use, N (%) | No ADM, N (%) | P † | |
|---|---|---|---|
| Implant-based reconstruction complications (tissue expanders and DTI) | |||
| Total | 26,266 | 23,100 | |
| Surgical site infection | 1224 (4.7) | 1018 (4.4) | 0.178 |
| Seroma | 1036 (3.9) | 934 (4.0) | 0.520 |
| Implant removal | 1308 (4.9) | 909 (3.9) | <0.001 |
| Any above complications | 2271 (8.7) | 1733 (7.5) | <0.001 |
| Direct-to-implant complications | |||
| Total | 4792 | 2715 | |
| Surgical site infection | 193 (4.0) | 120 (4.4) | 0.414 |
| Seroma | 170 (3.5) | 98 (3.6) | 0.889 |
| Implant removal | 393 (8.2) | 170 (6.3) | 0.002 |
| Any above complication | 509 (10.6) | 259 (9.5) | 0.137 |
See Table 3 for ICD Diagnosis Codes and CPT.
Pearson chi-squared test.